Literature DB >> 29122663

FTIR study of secondary structure changes in Epidermal Growth Factor by gold nanoparticle conjugation.

T T Bhattacharjee1, M L Castilho2, I R de Oliveira3, V P S Jesus2, K C Hewitt4, L Raniero5.   

Abstract

Conformation of protein is vital to its function, but may get affected when processing to manufacture products. It is therefore important to understand structural changes during each step of production. In this study, we investigate secondary structure changes in the targeting protein Epidermal Growth Factor (EGF) during synthesis of theranostic bifunctional nanoparticle, devised for Photodynamic therapy of breast cancer. We acquired FTIR spectra of EGF; unconjugated, post treatment with α-lipoic acid, attached to gold nanoparticle, and bound to the bifunctional nanoprobe. We observed decreasing disordered structures and turns, and increasing loops, as the synthesis process progressed. There was an overall increase in β-sheets in final product compared to pure EGF, but this increase was not linear and fluctuated. Previous crystal structure studies on EGF-EGFR complex have shown loops and β-sheets to be important in the binding interaction. Since our study found increase in these structures in the final product, no adverse effect on binding function of EGF was expected. This was confirmed by functional assays. Such studies may help modify synthesis procedures, and thus secondary structures of proteins, enabling increased functionality and optimum results.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bifunctional nanoprobe synthesis; Epidermal Growth Factor (EGF); FTIR; Gold nanoparticle; Secondary structure; Targeted Photodynamic therapy

Mesh:

Substances:

Year:  2017        PMID: 29122663     DOI: 10.1016/j.bbagen.2017.11.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gen Subj        ISSN: 0304-4165            Impact factor:   3.770


  2 in total

Review 1.  EGFR-Targeted Photodynamic Therapy.

Authors:  Luca Ulfo; Paolo Emidio Costantini; Matteo Di Giosia; Alberto Danielli; Matteo Calvaresi
Journal:  Pharmaceutics       Date:  2022-01-20       Impact factor: 6.321

Review 2.  Ligand-Targeted Delivery of Photosensitizers for Cancer Treatment.

Authors:  Piotr Gierlich; Ana I Mata; Claire Donohoe; Rui M M Brito; Mathias O Senge; Lígia C Gomes-da-Silva
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.